Sotac Pharmaceuticals Limited (NSEI: SOTAC)
Salud · Farmacéuticas · IN
129,35 Rs
-0,50 % hoy · +5,5 % 1 año
Sotac Pharmaceuticals Limited (NSEI: SOTAC) opera en la industria de farmacéuticas dentro del sector salud. Su valor en bolsa es de 15,20 M $ y tiene 127 empleados.
En los últimos doce meses la acción ha subido un 5,5 % y ha cotizado entre 86,00 y 139,65.
Tweenvest puntúa a Sotac Pharmaceuticals Limited en cuatro factores: calidad 61/100, valor 52/100, crecimiento 38/100, dividendo 39/100. Su punto más fuerte es calidad.
Evolución de la cotización de SOTAC
Cifras clave
- Capitalización
- 15,20 M $
- Ingresos (últ. 12 m)
- 14,34 M $
- PER
- 24,79
- BPA
- 7,82
- Rent. por dividendo
- 0,15 %
- Beta (5 años)
- -0,18
- Máximo 52 semanas
- 139,65 Rs
- Mínimo 52 semanas
- 86,00 Rs
- Volumen medio (3 m)
- —
- Acciones en circulación
- 11,05 M
- Empleados
- 127
- Próximos resultados
- —
Sobre Sotac Pharmaceuticals Limited
Sotac Pharmaceuticals Ltd. is an India-based company operating within the pharmaceutical industry, specializing in the manufacturing of a diverse range of pharmaceutical formulations. The company functions primarily as a Contract Development and Manufacturing Organization (CDMO) and third-party manufacturer, serving both domestic and international clients. Its product portfolio includes various finished formulations such as tablets (general, beta-lactam, coated, and uncoated), capsules (general and beta-lactam), oral liquids, dry syrups, and external preparations like nasal sprays, relief sprays, and creams. Sotac Pharmaceuticals produces pharmaceuticals across numerous therapeutic areas, including anti-diabetic, anti-psychotic, vitamin and mineral supplements, anti-cold, anti-allergic, dermatological, antacid, anti-ulcerant, anti-emetic, cardiac, anti-hypertensive, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (both IP-Lactams and Non-IP-Lactams), anti-fungal, and cephalosporin products. Beyond manufacturing, the company provides essential services to the pharmaceutical sector, including regulatory services, containment solutions, formulation development, clinical batch production, commercial scale production, and packaging. Sotac Pharmaceuticals exports globally, with the United States being a significant international market, and maintains a strong presence across India.
- ISIN
- INE0O2D01012
- Fundada en
- 2014
- Cotiza desde
- 13 abr 2023
- Bolsa
- National Stock Exchange of India
- Divisa
- INR
Otras empresas de farmacéuticas
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| MFC Co., Ltd.KOSE: A432980 | 15,44 M $ | 2400,00 ₩ | +5,96 % |
| Curis Lifesciences LimitedNSEI: CURIS | 15,39 M $ | 179,00 Rs | +4,86 % |
| Tdspharm Co., Ltd.KOSDAQ: A464280 | 15,23 M $ | 3670,00 ₩ | -1,61 % |
| Bal Pharma LimitedBSE: 524824 | 15,21 M $ | 90,10 Rs | +2,12 % |
| 1CM Inc.CNSX: EPIC | 15,18 M $ | 0,18 CA$ | 0,00 % |
| Par Drugs and Chemicals LimitedNSEI: PAR | 15,03 M $ | 114,11 Rs | +0,66 % |
| Panchsheel Organics LimitedBSE: 531726 | 14,90 M $ | 106,64 Rs | +0,32 % |
| Seoul Pharma Co., LtdKOSDAQ: A018680 | 14,80 M $ | 1695,00 ₩ | -1,57 % |